COPD

July 19, 2017July 19, 2017

Sunovion Divests US Market Rights on Asthma and Allergic Rhinitis Therapies to Focus on COPD

Asthma, COPD, News

Sunovion Pharmaceuticals has entered an agreement with Covis Pharma to divest the U.S. market rights of a series of products based on ciclesonides approved for the treatment of asthma and allergic rhinitis. Ciclesonides are in ... Read more

June 28, 2017June 28, 2017

Washington University to Sequence DNA of Lung Disease Patients Across Ethnic Groups

COPD, Idiopathic Pulmonary Fibrosis, News

The McDonnell Genome Institute at Washington University has received a $10 million U.S. government grant to map the DNA of patients from a number of ethnic groups who had chronic obstructive pulmonary disease ... Read more

May 24, 2017June 19, 2017

INOpulse Nitric Oxide System Seen to Treat PH Patients with IPF and COPD Symptoms

COPD, Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension

The INOpulse nitric oxide delivery system met its primary Phase 2 clinical trial goal of increasing the blood-vessel volume of pulmonary hypertension patients with idiopathic pulmonary fibrosis (PH-IPF), according to its maker, Bellerophon Therapeutics. ... Read more

May 23, 2017May 23, 2017

Adding Noninvasive Ventilator to At-home Oxygen Therapy Benefits COPD Patients

COPD, News

Adding a noninvasive ventilator to home oxygen therapy prolonged the time to hospital readmission for patients with chronic obstructive pulmonary disease (COPD) after an acute exacerbation. The study with the findings, ... Read more

May 10, 2017May 11, 2017

Pulmatrix Receives US Patent for PUR0200, an Inhaled Formulation for Lung Diseases

COPD, News

Pulmatrix has received a U.S. patent for PUR0200, an inhaled formulation of tiotropium bromide for lung diseases such as chronic obstructive pulmonary disease (COPD). The company said the powder it developed does a better ... Read more

May 4, 2017May 4, 2017

New Study Shows High Mortality, Healthcare Costs in Patients with Non-Tuberculosis Mycobacterial Disease

Bronchiectasis, COPD, News

A new European study indicates the financial burden and mortality associated with non-tuberculosis mycobacterium pulmonary disease (NTM-PD) is higher than previously suspected. The study reporting the findings, “Burden of non-tuberculous ... Read more

April 24, 2017April 24, 2017

British Researchers Develop One-Hour Flu and Viral Infections Test

Asthma, COPD, News

British researchers have developed an innovative approach to using a swab test to diagnose flu and other viral infections in patients with respiratory conditions, resulting in shorter courses of antibiotics ... Read more

April 17, 2017April 17, 2017

MURDOCK Study Aims to Determine Real-World Impact of COPD

COPD, News

The Duke Clinical Research Institute (DCRI), the MURDOCK Study and Boehringer Ingelheim are collaborating on a new observational study to understand the real-world impact of chronic obstructive pulmonary disease (COPD). ... Read more

April 7, 2017April 7, 2017

Lung Institute Wants to Raise Awareness of COPD-Depression Link on World Health Day

COPD, News

The Lung Institute is trying to raise awareness of the link between chronic obstructive pulmonary disease (COPD) and depression in honor of World Health Day, whose focus this year is depression. ... Read more

April 3, 2017April 3, 2017

Stem Cells Reduce Lung Inflammation and Damage in Mouse Model of COPD and Cystic Fibrosis

COPD, Cystic Fibrosis, News

A ground-breaking experiment using mesenchymal stem cells (MSCs) injected into mice models of chronic obstructive pulmonary disease (COPD) and cystic fibrosis showed that MSC therapy might be a promising approach to ... Read more